NGM Biopharmaceutica Stock Forecast - Naive Prediction

NGM Stock Forecast is based on your current time horizon.
  
A naive forecasting model for NGM Biopharmaceutica is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of NGM Biopharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.
This model is not at all useful as a medium-long range forecasting tool of NGM Biopharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict NGM Biopharmaceutica. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for NGM Biopharmaceutica

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NGM Biopharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NGM Biopharmaceutica. Your research has to be compared to or analyzed against NGM Biopharmaceutica's peers to derive any actionable benefits. When done correctly, NGM Biopharmaceutica's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NGM Biopharmaceuticals.

View NGM Biopharmaceutica Related Equities

 Risk & Return  Correlation

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in NGM Stock

If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Trending Assets

ASMB
Assembly Biosciences
10.90  0.09  0.83 
PRLD
Prelude Therapeutics
0.68  0.04  6.25 
RZLT
Rezolute
2.92  0.19  6.96 
ACHL
Achilles Therapeutics PLC
1.48  0.00  0.00 
NXTC
NextCure
0.53  -0.04  -7.02 
FHTX
Foghorn Therapeutics
3.88  0.07  1.84 
CYT
Cyteir Therapeutics
0.00  0.00  0.00 
MLYS
Mineralys Therapeutics,
15.00  -1.15  -7.12 
NKTX
Nkarta Inc
1.97  0.60  43.80 
KROS
Keros Therapeutics
10.99  -0.02  -0.18 
ERAS
Erasca Inc
1.55  0.07  4.73 
GBIO
Generation Bio
0.46  -0.01  -2.13 
GLUE
Monte Rosa Therapeutics
5.26  -0.23  -4.19 
IPSC
Century Therapeutics
0.55  -0.01  -1.79 
LYEL
Lyell Immunopharma
0.59  0.03  5.36 
SANA
Sana Biotechnology
1.85  0.04  2.21 
KZR
Kezar Life Sciences
5.13  -0.04  -0.77 
TIL
Instil Bio
19.36  1.37  7.62 
NLTX
Neoleukin Therapeutics
0.00  0.00  0.00 
CCCC
C4 Therapeutics
1.84  -0.01  -0.54 
News Freq…Investor S…